Next Article in Journal
3′,4′-Dihydroxyflavonol Modulates the Cell Cycle in Cancer Cells: Implication as a Potential Combination Drug in Osteosarcoma
Next Article in Special Issue
Exploiting the Metabolism of the Gut Microbiome as a Vehicle for Targeted Drug Delivery to the Colon
Previous Article in Journal
Novel Purine Chemotypes with Activity against Plasmodium falciparum and Trypanosoma cruzi
Previous Article in Special Issue
Drug–Drug Interactions and Pharmacogenomic Evaluation in Colorectal Cancer Patients: The New Drug-PIN® System Comprehensive Approach
 
 
Article

Article Versions Notes

Pharmaceuticals 2021, 14(7), 639; https://doi.org/10.3390/ph14070639
Action Date Notes Link
article xml file uploaded 1 July 2021 13:34 CEST Original file -
article xml uploaded. 1 July 2021 13:34 CEST Update -
article pdf uploaded. 1 July 2021 13:34 CEST Version of Record https://www.mdpi.com/1424-8247/14/7/639/pdf-vor
article supplementary file uploaded. 1 July 2021 13:34 CEST - https://www.mdpi.com/1424-8247/14/7/639#supplementary
article html file updated 1 July 2021 13:36 CEST Original file -
article xml file uploaded 14 July 2021 05:18 CEST Update -
article xml uploaded. 14 July 2021 05:18 CEST Update https://www.mdpi.com/1424-8247/14/7/639/xml
article pdf uploaded. 14 July 2021 05:18 CEST Updated version of record https://www.mdpi.com/1424-8247/14/7/639/pdf
article html file updated 14 July 2021 05:20 CEST Update -
article html file updated 27 July 2022 03:03 CEST Update https://www.mdpi.com/1424-8247/14/7/639/html
Back to TopTop